StockData
Merck & Co., Inc. logo

Merck & Co., Inc. (MRK) stock

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/30240% above fair value
$143.37−1.09 (-0.75%)

Close on Nov 17, 2026Market cap $353.72BP/E 114.7Yield 2.29%

Merck price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Merck's price to book ratio was 8.8× on Nov 10, 2026, against 5.1× a year earlier. Over the last 5 years it ranged from 4.0× to 8.9×, with a median of 5.9×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 10, 20268.8×+3.6
2025Dec 31, 20255.1×−0.6
2024Dec 31, 20245.7×−1.0
2023Dec 29, 20236.7×+0.4
2022Dec 30, 20226.3×+0.9
2021Dec 31, 20215.4×−1.7
2020Dec 31, 20207.1×−1.7
2019Dec 31, 20198.8×+2.4
2018Dec 31, 20186.4×+2.3
2017Dec 29, 20174.1×+0.3
2016Dec 30, 20163.8×+0.4
2015Dec 31, 20153.3×−0.4
2014Dec 31, 20143.8×+0.6
2013Dec 31, 20133.2×+1.0
2012Dec 31, 20122.3×+0.4
2011Jan 31, 20111.8×−0.2
2010Dec 31, 20102.0×–

More Merck figures

See a number that looks wrong?